Angiogenesis as a predictive marker of neurological outcome following hypoxia-ischemia

Brain Research

Volumn 1171, Issue 1, 2007, Pages 111-121

  Clarkson, Andrew N ^a   Liu, Hanzhong ^a   Schiborra, Fredericke ^a   Shaw, Odette ^a   Sammut, Ivan A ^a   Jackson, David M ^a,b   Appleton, Ian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

CD31; Clomethiazole; Inflammation; l NAME; NOS

Indexed keywords

ARGINASE; CD31 ANTIGEN; CLOMETHIAZOLE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; BRAIN BLOOD VESSEL; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD31; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BRAIN; CHLORMETHIAZOLE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HYPOXIA-ISCHEMIA, BRAIN; INTERLEUKIN-1BETA; MALE; NEOVASCULARIZATION, PATHOLOGIC; NEUROPROTECTIVE AGENTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PREDICTIVE VALUE OF TESTS; RATS; RATS, WISTAR;

EID: 34548642268     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.06.100     Document Type: Article

References (45)

1. Appleton I. Wound healing: future directions. IDrugs 6 (2003) 1067-1072
2. Appleton I., Brown N.J., Willis D., Colville-Nash P.R., Alam C., Brown J.R., and Willoughby D.A. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J. Pathol. 180 (1996) 90-94
3. Baldwin H.S., Shen H.M., Yan H.C., DeLisser H.M., Chung A., Mickanin C., Trask T., Kirschbaum N.E., Newman P.J., and Albelda S.M. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120 (1994) 2539-2553
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
5. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11 (1993) 767-804
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Buchan A.M., Gertler S.Z., Huang Z.G., Li H., Chaundy K.E., and Xue D. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase. Neuroscience 61 (1994) 1-11
8. Buisson A., Plotkine M., and Boulu R.G. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol. 106 (1992) 766-767
9. Clarkson A.N., Liu H., Pearson L., Kapoor M., Harrison J.C., Sammut I.A., Jackson D.M., and Appleton I. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB J. 18 (2004) 1114-1116
10. Clarkson A.N., Rahman R., and Appleton I. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?. Curr. Opin. Investig. Drugs 5 (2004) 706-713
11. Clarkson A.N., Liu H., Rahman R., Jackson D.M., Appleton I., and Kerr D.S. Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia-ischemia. FASEB J. 19 (2005) 1036-1038
12. Clarkson A.N., Sutherland B.A., and Appleton I. The biology and pathology of hypoxia-ischemia: an update. Arch. Immunol. Ther. Exp. (Warsz ). 53 (2005) 213-225
13. Clarkson A.N., Clarkson J., Jackson D.M., and Sammut I.A. Mitochondrial involvement in transhemispheric diaschisis following hypoxia-ischemia: clomethiazole-mediated amelioration. Neuroscience 144 (2007) 547-561
14. Colville-Nash P.R., Alam C.A., Appleton I., Brown J.R., Seed M.P., and Willoughby D.A. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J. Pharmacol. Exp. Ther. 274 (1995) 1463-1472
15. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
16. Dietrich W.D., Busto R., and Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 158 (1999) 444-450
17. Endres M., Laufs U., Liao J.K., and Moskowitz M.A. Targeting eNOS for stroke protection. Trends Neurosci. 27 (2004) 283-289
18. Escott K.J., Beech J.S., Haga K.K., Williams S.C., Meldrum B.S., and Bath P.M. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 281-287
19. Ferriero D.M., Holtzman D.M., Black S.M., and Sheldon R.A. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol. Dis. 3 (1996) 64-71
20. Ha H.C., Woster P.M., Yager J.D., and Casero Jr. R.A. The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11557-11562
21. Ha H.C., Sirisoma N.S., Kuppusamy P., Zweier J.L., Woster P.M., and Casero Jr. R.A. The natural polyamine spermine functions directly as a free radical scavenger. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11140-11145
22. Harmon D., Coleman E., Marshall C., Lan W., and Shorten G. The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation. Anesth. Analg. 97 (2003) 13-18 (table)
23. Hayashi T., Noshita N., Sugawara T., and Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 166-180
24. Hu J., Mahmoud M.I., and el-Fakahany E.E. Polyamines inhibit nitric oxide synthase in rat cerebellum. Neurosci. Lett. 175 (1994) 41-45
25. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., and Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine. J. Cereb. Blood Flow Metab. 16 (1996) 981-987
26. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139
27. Iadecola C., Zhang F., Casey R., Nagayama M., and Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17 (1997) 9157-9164
28. Jude E.B., Boulton A.J., Ferguson M.W., and Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 42 (1999) 748-757
29. Kapoor M., Howard R., Hall I., and Appleton I. Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am. J. Pathol. 165 (2004) 299-307
30. Krupinski J., Kaluza J., Kumar P., Kumar S., and Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25 (1994) 1794-1798
31. Kuluz J.W., Prado R.J., Dietrich W.D., Schleien C.L., and Watson B.D. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24 (1993) 2023-2029
32. Lee H.J., Kim K.S., Park I.H., and Kim S.U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2 (2007) e156
33. McPherson R.J., Demers E.J., and Juul S.E. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 91 (2007) 36-43
34. Molina-Holgado E., Vela J.M., revalo-Martin A., and Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13 (2001) 493-502
35. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 100 (1997) S25-S29
36. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
37. Simi A., Ingelman-Sundberg M., and Tindberg N. Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase. J. Cereb. Blood Flow Metab. 20 (2000) 1077-1088
38. Simi A., Porsmyr-Palmertz M., Hjerten A., Ingelman-Sundberg M., and Tindberg N. The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cells. J. Neurochem. 83 (2002) 727-737
39. Slevin M., Kumar P., Gaffney J., Kumar S., and Krupinski J. Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin. Sci. (Lond.) 111 (2006) 171-183
40. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 (2005) 1672-1678
41. Sutherland B.A., Shaw O.M., Clarkson A.N., Jackson D.N., Sammut I.A., and Appleton I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action. FASEB J. 19 (2005) 258-260
42. Tabor C.W., and Tabor H. Polyamines. Annu. Rev. Biochem. 53 (1984) 749-790
43. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
44. Zhang Z.G., Zhang L., Jiang Q., and Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90 (2002) 284-288
45. Zhou Z., Christofidou-Solomidou M., Garlanda C., and DeLisser H.M. Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 3 (1999) 181-188